Immunosuppressive serum factors in viral hepatitis. III. Prognostic relevance of rosette inhibitory factor and serum inhibition factor in acute and chronic hepatitis.
Two immunosuppressive serum factors, serum inhibition factor (SIF) and rosette inhibitory factor (RIF), were studied in sera from patients with acute and chronic viral hepatitis. In a study of 30 patients with acute viral hepatitis, an association was found between RIF, SIF, and biochemical and virological parameters in 27 patients (90%), 25 of whom recovered completely; two had a protracted course. In three patients, the clinical course was not reflected by the immunosuppressive factors. In 26 patients with chronic persistent hepatitis, 3 had RIF and 7 had SIF of low activity. In patients with HBsAg-positive and -negative chronic active hepatitis, 32 of 47 had RIF and 24 had SIF. SIF activity was significantly increased in HBsAg positive as compared to -negative cases. There was no correlation between RIF and SIF activity at any stage of viral hepatitis. Although SIF was demonstrated in patients with various infectious and other inflammatory diseases, RIF was infrequently detected in nonviral liver disorders, and was not present in any of the nonhepatic diseases tested. It was confirmed that RIF is associated with the beta-lipoprotein fraction. RIF was easily separated from SIF by density gradient ultracentrifugation. The evaluation of SIF and RIF may be helpful in determining the outcome of acute viral hepatitis. In chronic hepatitis, RIF was a better indicator of disease activity than was SIF. These clinical data support previous findings that SIF may be related to the immune response whereas RIF is associated with liver cell damage.
D000208:Acute Disease; D000410:Alanine Transaminase / Q000032:analysis; D001798:Blood Proteins / Q000032:analysis*; D002908:Chronic Disease; D006023:Glycoproteins / Q000032:analysis*; D006514:Hepatitis B Surface Antigens / Q000032:analysis; D006525:Hepatitis, Viral, Human / Q000276:immunology*; D006801:Humans; D008077:Lipoproteins, LDL; D008107:Liver Diseases / Q000276:immunology; D009363:Neoplasm Proteins; D011379:Prognosis
D001798:Blood Proteins; D006023:Glycoproteins; D006514:Hepatitis B Surface Antigens; D008077:Lipoproteins, LDL; D009363:Neoplasm Proteins; C022060:rosette-inhibiting factor; C038588:serum immunosuppressive factor, human; D000410:Alanine Transaminase